In a murine model of breast cancer, TAMs are also demonstrated to promote CSC phenotypes in breast cancer cells through the EGF-mediated STAT3/SOX-2 cascade, and this cross talk could be abrogated by small molecule inhibitors against EGFR or STAT3 [49]. Here, EGF is linked to breast carcinoma.